I have been a investor in DNDN for 3 years now and have been through the ups and downs of the pops and the drops. ITMN reminds me of DNDN when the panel recommended it and the FDA rejected it. We then saw it fall as far in the 3 dollar range.
Everyone keeps claiming this is a blockbuster drug...well, so was that...and the FDA has to make sure its safe for people with these ugly illnesses. Let remember whats behind the stock guys...If the drug isnt safe or can present harm to someone then the FDA will not approve.
I see this getting an approvable letter / rejection just as the same as DNDN did. I think another trial for more data will present this opportunity again in YEARS from now, therefore i have the stock going all the way to 10 and possibly below by July. (take a look at volume in July 10 and 7.50 puts).
ITMN will be approved one day, but i think they need to put more work into their study at this point to make it more precise. Once and if it falls into the teens/10$ range, I will be buying up call options.
GL to all with decision, and if it gets approved and the shorts lose money...just remember how the new drug will help these sick people who would pay infinite amounts of money to have their illness go away.